Why is Orchid Pharma falling/rising?

As of 19-Sep, Orchid Pharma Ltd's stock price is currently at Rs 788.55, reflecting an increase of Rs 71.65 or 9.99%. The stock has shown strong performance recently, gaining 11.31% over the last three days and outperforming its sector by 9.72% today. Despite this positive short-term movement, the company has faced significant challenges, including a weak long-term fundamental strength characterized by a low return on equity (ROE) of 4.68% and a declining operating profit. The company has reported negative results for the last three consecutive quarters, with a notable drop in profit after tax and a concerning EBIT to interest ratio of 1.99, which raises questions about its ability to service debt.
In the broader market context, Orchid Pharma's recent performance contrasts sharply with the benchmark, as it has outperformed the Sensex by 11.53% over the past week, while the Sensex itself has only increased by 0.88%. However, the stock's year-to-date performance remains troubling, with a decline of 56.61% compared to the Sensex's gain of 5.74%. This disparity highlights the stock's volatility and the challenges it faces in regaining investor confidence, despite recent gains. Overall, while the stock is experiencing a short-term rise, its long-term outlook remains precarious due to ongoing financial struggles.